Formation of large vacuoles induced by cooperative effects of oncostatin M and dexamethasone in human fetal liver cells

Medical Molecular Morphology

Volumn 41, Issue 1, 2008, Pages 53-58

  Matsunaga, Tamihide ^a   Toba, Mie ^a   Teramoto, Tsuyoshi ^a   Mizuya, Mitsue ^a   Aikawa, Kaori ^a   Ohmori, Shigeru ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dexamethasone; Human fetal liver cells; Morphology; Oncostatin M; Vacuole

Indexed keywords

DEXAMETHASONE; ONCOSTATIN M;

ARTICLE; CELL MEMBRANE; CELL ORGANELLE; CELL SWELLING; CELL VACUOLE; CYTOPLASM; ELECTRON MICROSCOPE; FETUS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; DRUG SYNERGISM; FETUS; HEPATOCYTES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; ONCOSTATIN M; VACUOLES;

EID: 43549122578     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-007-0387-2     Document Type: Article

References (27)

1. Gomez-Lechon MJ (1999) Oncostatin M. Signal transduction and biological activity. Life Sci 65:2019-2030
2. Tanaka M, Miyajima A (2003) Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39-52
3. Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, Hara T (2000) Role of oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev 11:177-183
4. Kamiya A, Kinoshita T, Ito Y, Matsui T, Morikawa Y, Senba E, Nakashima, K, Taga T, Yoshida K, Kishimoto T, Miyajima A (1999) Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 18: 2127-2136
5. Kinoshita T, Sekiguchi T, Xu MJ, Ito Y, Kamiya A, Tsuji K, Nakahata T, Miyajima A (1999) Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A 96:7265-7270
6. La'zaro CA, Croager EJ, Mitchell C, Campbell JS, Yu C, Foraker J, Rhim JA, Yeoh GC, Fausto N (2003) Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 38:1095-1106
7. Andrade MVM, Hiragun T, Beaven MA (2004) Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J Immunol 172: 7254-7262
8. Johnson EE, Overmeyer JH, Gunning WT, Maltese WA (2006) Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes. J Cell Sci 119:1219-1232
9. Reaves BJ, Bright NA, Mullock BM, Luzio JP (1996) The effect of wortmannin on the localisation of lysosomal type I integral membrane glycoproteins suggests a role for phosphoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway. J Cell Sci 109:749-762
10. Smyth DC, Kerr C, Richards CD (2006) Oncostatin M-induced IL-6 expression in murine fibroblasts requires the activation of protein kinase Cδ. J Immunol 177:8740-8747
11. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, Papini E, Montecucco C, Parente L, Rappuoli R (1994) Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 179:1653-1658
12. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270: 17771-17777
13. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simoes M (2002) Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94:1680-1687
14. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T, Fukamachi H (2003) Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 33:375-381
15. Papini E, Zoratti M, Cover TL (2001) In search of the Helicobacter pylori VacA mechanism of action. Toxicon 39:1757-1767
16. Montecucco C, de Bernard M (2003) Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 5:715-721
17. Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y (2002) A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci 115:4117-4131
18. Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, Tanaka Y, Lullmann-Rauch R, Hartmann D, Heeren J, von Figura K, Knecht E, Saftig P (2004) Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 15:3132-3145
19. Kaul A, Overmeyer JH, Maltese WA (2007) Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways. Cell Signal 19:1034-1043
20. Ohkuma S, Poole B (1981) Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 90:656-664
21. Maruyama M, Matsunaga T, Harada E, Ohmori S (2007) Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull 30:2091-2097
22. Luzio JP, Rous BA, Bright NA, Pryor PR, Mullock BM (2000) Lysosome-endosome fusion and lysosome biogenesis. J Cell Biol 113:1515-1524
23. Luzio JP, Mullock BM, Pryor PR, Lindsay MR, James DE, Piper RC (2001) Relationship between endosomes and lysosomes. Biochem Soc Trans 29:476-480
24. Ishibashi H, Komori A, Shimoda S, Gershwin ME (2007) Guidelines for therapy of autoimmune liver disease. Semin Liver Dis 27:214-226
25. Tilg H, Day CP (2007) Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol 4:24-34
26. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A (2004) Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39:635-644
27. Hamada T, Sato A, Hirano T, Yamamoto T, Son G, Onodera M, Torii I, Nishigami, Tanaka M, Miyajima A, Nishiguchi S, Fujimoto J, Tsujimura T (2007) Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosoamine in rats. Am J Pathol 171:872-881